JP2003502278A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003502278A5 JP2003502278A5 JP2000593602A JP2000593602A JP2003502278A5 JP 2003502278 A5 JP2003502278 A5 JP 2003502278A5 JP 2000593602 A JP2000593602 A JP 2000593602A JP 2000593602 A JP2000593602 A JP 2000593602A JP 2003502278 A5 JP2003502278 A5 JP 2003502278A5
- Authority
- JP
- Japan
- Prior art keywords
- alkoxy
- alkyl
- hydrogen
- substituted
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99100693 | 1999-01-15 | ||
| EP99100693.3 | 1999-01-15 | ||
| PCT/EP2000/000192 WO2000042034A1 (en) | 1999-01-15 | 2000-01-13 | Phenanthridine-n-oxides with pde-iv inhibiting activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003502278A JP2003502278A (ja) | 2003-01-21 |
| JP2003502278A5 true JP2003502278A5 (cg-RX-API-DMAC7.html) | 2007-03-01 |
Family
ID=8237350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000593602A Withdrawn JP2003502278A (ja) | 1999-01-15 | 2000-01-13 | 新規のn−オキシド |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6534519B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1147103B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003502278A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE294793T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2290000A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2359449A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60019894T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1147103T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2241571T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1147103E (cg-RX-API-DMAC7.html) |
| SI (1) | SI1147103T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2000042034A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EE05105B1 (et) * | 1999-01-15 | 2008-12-15 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Fenlfenantridiinid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim |
| WO2001051470A1 (en) | 2000-01-11 | 2001-07-19 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridine-n-oxides |
| SI1303506T1 (en) | 2000-07-14 | 2005-06-30 | Altana Pharma Ag | 6-heteroarylphenanthridines |
| AU2003255493B8 (en) * | 2002-08-29 | 2009-03-26 | Takeda Gmbh | 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors |
| CA2496459C (en) * | 2002-08-29 | 2013-06-25 | Altana Pharma Ag | 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| EP1658270A1 (en) * | 2003-07-31 | 2006-05-24 | ALTANA Pharma AG | Novel 6-phenylphenantridines |
| JP2007500686A (ja) * | 2003-07-31 | 2007-01-18 | アルタナ ファルマ アクチエンゲゼルシャフト | 新規の6−フェニルフェナントリジン |
| US20050187278A1 (en) * | 2003-08-28 | 2005-08-25 | Pharmacia Corporation | Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors |
| WO2005023253A1 (en) * | 2003-09-05 | 2005-03-17 | Altana Pharma Ag | Use of pde4 inhibitors for the treatment of diabetes mellitus |
| EP1720835B1 (en) | 2004-02-18 | 2012-12-12 | Nycomed GmbH | Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors |
| PL2589599T4 (pl) | 2004-03-03 | 2015-06-30 | Takeda Gmbh | Nowe hydroksy-6-heteroarylofenantrydyny i ich zastosowanie jako inhibitorów PDE4 |
| AR049419A1 (es) * | 2004-03-03 | 2006-08-02 | Altana Pharma Ag | Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo |
| MXPA06009892A (es) * | 2004-03-10 | 2007-03-01 | Altana Pharma Ag | Nuevas hidroxi-6-fenilfenantridinas sustituidas con amido y su uso como inhibidores de la fosfodiesterasa tipo 4 (pde4). |
| ES2337083T3 (es) | 2005-03-02 | 2010-04-20 | Nycomed Gmbh | (2r,4ar,10br)-6-(2,6-dimetoxipiridin-3-il)-9-exoti-8-metoxi-1,2,3,4,4a,10b-hexahidrofenantridin-2-ol, sal de hc1. |
| CN102600144A (zh) | 2005-03-08 | 2012-07-25 | 奈科明有限责任公司 | 治疗糖尿病的罗氟司特 |
| KR101178674B1 (ko) | 2007-10-04 | 2012-08-30 | 에프. 호프만-라 로슈 아게 | 사이클로프로필 아릴 아마이드 유도체 및 이의 용도 |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5455252A (en) * | 1993-03-31 | 1995-10-03 | Syntex (U.S.A.) Inc. | Optionally substituted 6,8-quinolines |
| US5475003A (en) * | 1994-03-03 | 1995-12-12 | Syntex (U.S.A.) Inc. | 8-phenylcyclopentenoquinoline and 8-phenylcyclohexenoquinoline derivatives |
| CA2143143A1 (en) * | 1994-03-08 | 1995-09-09 | Toshihiko Tanaka | 3-phenylpyrrolidine derivatives |
| US5466697A (en) * | 1994-07-13 | 1995-11-14 | Syntex (U.S.A.) Inc. | 8-phenyl-1,6-naphthyridin-5-ones |
| EE03523B1 (et) | 1996-01-31 | 2001-10-15 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine |
| US6127378A (en) | 1996-03-26 | 2000-10-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridines substituted in the 6 position |
| CA2250569C (en) * | 1996-03-26 | 2005-05-10 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel phenanthridines substituted in the 6 position |
| GB9622386D0 (en) | 1996-10-28 | 1997-01-08 | Sandoz Ltd | Organic compounds |
| DK0937074T3 (da) | 1996-11-11 | 2003-06-23 | Altana Pharma Ag | Benzonaphthyridiner som bronkiale terapeutiske midler |
| GB9626643D0 (en) | 1996-12-21 | 1997-02-12 | Astra Pharma Prod | Compounds |
| SI0968211T1 (en) * | 1997-03-07 | 2004-02-29 | Altana Pharma Ag | Tetrazole derivatives |
| AU8106598A (en) | 1997-06-03 | 1998-12-21 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzonaphthyridine |
| AU753615B2 (en) | 1997-07-25 | 2002-10-24 | Altana Pharma Ag | Novel tetrazole derivatives |
| SI1109810T1 (en) | 1998-08-31 | 2004-12-31 | Altana Pharma Ag | Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity |
-
2000
- 2000-01-13 EP EP00901539A patent/EP1147103B1/en not_active Expired - Lifetime
- 2000-01-13 AT AT00901539T patent/ATE294793T1/de not_active IP Right Cessation
- 2000-01-13 AU AU22900/00A patent/AU2290000A/en not_active Abandoned
- 2000-01-13 US US09/889,146 patent/US6534519B1/en not_active Expired - Fee Related
- 2000-01-13 SI SI200030713T patent/SI1147103T1/xx unknown
- 2000-01-13 DE DE60019894T patent/DE60019894T2/de not_active Expired - Fee Related
- 2000-01-13 DK DK00901539T patent/DK1147103T3/da active
- 2000-01-13 CA CA002359449A patent/CA2359449A1/en not_active Abandoned
- 2000-01-13 JP JP2000593602A patent/JP2003502278A/ja not_active Withdrawn
- 2000-01-13 ES ES00901539T patent/ES2241571T3/es not_active Expired - Lifetime
- 2000-01-13 PT PT00901539T patent/PT1147103E/pt unknown
- 2000-01-13 WO PCT/EP2000/000192 patent/WO2000042034A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002506856A5 (cg-RX-API-DMAC7.html) | ||
| JP2002534508A5 (cg-RX-API-DMAC7.html) | ||
| CA2373653C (en) | New use of compounds as antibacterial agents | |
| JP2002517491A5 (cg-RX-API-DMAC7.html) | ||
| JP2003501474A5 (cg-RX-API-DMAC7.html) | ||
| EP1236719A4 (en) | NOVEL HETEROCYCLIC COMPOUNDS AND SALTS THEREOF, USE OF THESE COMPOUNDS IN MEDICINE | |
| JP2006508913A5 (cg-RX-API-DMAC7.html) | ||
| JP2006500370A5 (cg-RX-API-DMAC7.html) | ||
| JP2003500442A5 (cg-RX-API-DMAC7.html) | ||
| WO2004113270A3 (en) | Propionic acid derivatives useful in the treatment of lipid disorders | |
| JP2008509187A5 (cg-RX-API-DMAC7.html) | ||
| JP2010529147A5 (cg-RX-API-DMAC7.html) | ||
| DK0893998T4 (da) | Afgivelse af nikotin i tyktarmen med henblik på behandling af inflammatoriske tarmsygdomme | |
| JP2007517043A5 (cg-RX-API-DMAC7.html) | ||
| JP2002534506A5 (cg-RX-API-DMAC7.html) | ||
| RU99101081A (ru) | Режим введения ингибиторов н+, к+-атфазы | |
| JP2002534507A5 (cg-RX-API-DMAC7.html) | ||
| NO20050569L (no) | Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette | |
| ATE479433T1 (de) | Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel | |
| KR960022472A (ko) | 3-페닐이소퀴놀-1(2h)-온 유도체와 그것의 제법 및 치료학적 이용 | |
| WO2000068198A3 (en) | Heterosubstituted pyridine derivatives as pde 4 inhibitors | |
| EP1184034A3 (en) | Oral drug composition containing a verapamil derivative as a drug-absorption promotor | |
| JP2001520994A5 (cg-RX-API-DMAC7.html) | ||
| WO2003082329A3 (en) | Compositions and compounds for use as molecular adjuvant for a nicotine vaccine | |
| JP2004315496A5 (cg-RX-API-DMAC7.html) |